
Brain Cancer Vaccine Doubles Survival in Early Trial
A personalized DNA vaccine for glioblastoma, one of the deadliest brain cancers, helped patients live twice as long as usual in a groundbreaking trial. One patient remains cancer-free nearly five years later.

















